Dr. Kartik Sehgal
Claim this profileDana-Farber Cancer Institute
Studies Squamous Cell Carcinoma
Studies Cancer
6 reported clinical trials
12 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
Stage III
p16 negative
2Cancer
Stage IV
Stage III
PIK3CA positive
Affiliated Hospitals
Clinical Trials Kartik Sehgal is currently running
IO102-IO103 + Pembrolizumab
for Resectable Cancer
This is a multicenter, multi-arm trial evaluating anti-tumor activity, safety, and immune infiltration of IO102-IO103 in combination with pembrolizumab KEYTRUDA® as neoadjuvant and post-surgery treatment. This proof-of-concept trial will include patients with resectable tumors in at least 2 indications.
Recruiting1 award Phase 219 criteria
Immunotherapy + Chemotherapy
for Resectable Head and Neck Cancer
This research study is evaluating effectiveness and safety of a combination of immunotherapy drug, pembrolizumab, with chemotherapy, as a possible treatment before and after surgery for squamous cell carcinoma of the head and neck (HNSCC). The combination of pembrolizumab and chemotherapy will be given prior to your surgery, while immunotherapy pembrolizumab will be continued for approximately 1 year after surgery. The names of the study drugs involved in this research study are: * pembrolizumab (a type of immunotherapy) * docetaxel (a type of chemotherapy) * cisplatin (a type of chemotherapy) * carboplatin (a type of chemotherapy)
Recruiting1 award Phase 2
More about Kartik Sehgal
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Kartik Sehgal has experience with
- Pembrolizumab
- Ipilimumab
- Nivolumab
- Carboplatin
- Cisplatin
- Docetaxel
Breakdown of trials Kartik Sehgal has run
Squamous Cell Carcinoma
Cancer
Thyroid Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kartik Sehgal specialize in?
Kartik Sehgal focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Kartik Sehgal currently recruiting for clinical trials?
Yes, Kartik Sehgal is currently recruiting for 4 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Kartik Sehgal has studied deeply?
Yes, Kartik Sehgal has studied treatments such as Pembrolizumab, Ipilimumab, Nivolumab.
What is the best way to schedule an appointment with Kartik Sehgal?
Apply for one of the trials that Kartik Sehgal is conducting.
What is the office address of Kartik Sehgal?
The office of Kartik Sehgal is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.